It primarily promoted the expression of p53 and Bax protein in NPC HK-1 cells via regulation of the PI3K/AKT/NF-κB pathway and inhibited the expression of cyclin D protein69. The gene discussed is PIK3CA; the disease is nasopharyngeal carcinoma.